{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:03:18Z","timestamp":1792202598678,"version":"4.4.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972002"],"award-info":[{"award-number":["81972002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["12304241"],"award-info":[{"award-number":["12304241"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012620","name":"Taishan Scholar Foundation of Shandong Province","doi-asserted-by":"publisher","award":["tsqnz20231257"],"award-info":[{"award-number":["tsqnz20231257"]}],"id":[{"id":"10.13039\/100012620","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2025QC852"],"award-info":[{"award-number":["ZR2025QC852"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2022QH392"],"award-info":[{"award-number":["ZR2022QH392"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023QC168"],"award-info":[{"award-number":["ZR2023QC168"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.mtbio.2026.102877","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:47:12Z","timestamp":1770223632000},"page":"102877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Targeting FN1 to overcome gemcitabine resistance in gallbladder cancer: Mechanistic insights and an iRGD-modified PEG-PLGA nanoparticle delivery strategy"],"prefix":"10.1016","volume":"37","author":[{"given":"Maojin","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangwei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9311-1927","authenticated-orcid":false,"given":"Peiqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mtbio.2026.102877_bib1","article-title":"A review of the etiology and epidemiology of gallbladder cancer: what you need to know","author":"Halaseh","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.mtbio.2026.102877_bib2","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/cam4.1044","article-title":"Trend analysis and survival of primary gallbladder cancer in the United States: a 1973\u20132009 population\u2010based study","volume":"6","author":"Rahman","year":"2017","journal-title":"Cancer Med."},{"key":"10.1016\/j.mtbio.2026.102877_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.21037\/cco.2019.08.13","article-title":"Gallbladder cancer: epidemiology and genetic risk associations","volume":"8","author":"Schmidt","year":"2019","journal-title":"Chin. Clin. Oncol."},{"key":"10.1016\/j.mtbio.2026.102877_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-61762-4","article-title":"In silico analysis unveiling potential biomarkers in gallbladder carcinogenesis","volume":"14","author":"Gupta","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mtbio.2026.102877_bib5","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3346\/jkms.2014.29.10.1333","article-title":"Practical guidelines for the surgical treatment of gallbladder cancer","volume":"29","author":"Lee","year":"2014","journal-title":"J. Kor. Med. Sci."},{"key":"10.1016\/j.mtbio.2026.102877_bib6","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1097\/MS9.0000000000001665","article-title":"Establishment and characterization of the gemcitabine-resistant human gallbladder cancer cell line NOZ GemR","volume":"86","author":"Xu","year":"2024","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.mtbio.2026.102877_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2023.102054","article-title":"MicroRNA-451a inhibits gemcitabine-refractory biliary tract cancer progression by suppressing the MIF-mediated PI3K\/AKT pathway","volume":"34","author":"Obata","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.mtbio.2026.102877_bib8","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1080\/14656566.2023.2259802","article-title":"FGFR inhibitor resistance in cholangiocarcinoma: current understanding and future directions","volume":"24","author":"Neureiter","year":"2023","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.mtbio.2026.102877_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1320084","article-title":"Editorial: novel therapeutic approaches for biliary tract cancer and hepatocellular carcinoma","volume":"11","author":"Bekric","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.mtbio.2026.102877_bib10","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.18632\/oncotarget.13907","article-title":"The role of tumor microenvironment in therapeutic resistance","volume":"8","author":"Son","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.mtbio.2026.102877_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176357","article-title":"Advance in the role of chemokines\/chemokine receptors in carcinogenesis: focus on pancreatic cancer","volume":"967","author":"Song","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.mtbio.2026.102877_bib12","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1097\/JS9.0000000000001226","article-title":"Single dual-specific anti-PD-L1\/TGF-\u03b2 antibody synergizes with chemotherapy as neoadjuvant treatment for pancreatic ductal adenocarcinoma: a preclinical experimental study","volume":"110","author":"Zhang","year":"2024","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.mtbio.2026.102877_bib13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10555-024-10168-9","article-title":"Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation","volume":"43","author":"Ashrafizadeh","year":"2024","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.mtbio.2026.102877_bib14","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.3390\/nano13212887","article-title":"Application of nanoparticles in cancer treatment: a concise review","volume":"13","author":"Sell","year":"2023","journal-title":"Nanomaterials"},{"key":"10.1016\/j.mtbio.2026.102877_bib15","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.7150\/ijms.49801","article-title":"Application of nanotechnology in cancer diagnosis and therapy - a mini-review","volume":"17","author":"Jin","year":"2020","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.mtbio.2026.102877_bib16","first-page":"384","article-title":"Advances in nanotechnology-based drug delivery systems in the treatment of hepatocellular carcinoma","volume":"46","author":"Yang","year":"2024","journal-title":"Acta Acad. Med. Sin."},{"key":"10.1016\/j.mtbio.2026.102877_bib17","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1021\/acsabm.3c00711","article-title":"Advances in peptide-decorated targeted drug delivery: exploring therapeutic potential and nanocarrier strategies","volume":"7","author":"Buddhiraju","year":"2023","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.mtbio.2026.102877_bib18","doi-asserted-by":"crossref","first-page":"8304","DOI":"10.3390\/ijms25158304","article-title":"Targeted nanocarrier-based drug delivery strategies for improving the therapeutic efficacy of PARP inhibitors against ovarian cancer","volume":"25","author":"Gralewska","year":"2024","journal-title":"IJMS"},{"key":"10.1016\/j.mtbio.2026.102877_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.69613\/rj09v621","article-title":"Recent advances in nanomedicine","volume":"3","author":"Trylockya Nagumantri","year":"2025","journal-title":"JOPIR"},{"key":"10.1016\/j.mtbio.2026.102877_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s40164-024-00521-7","article-title":"Multi-model analysis of gallbladder cancer reveals the role of OxLDL-absorbing neutrophils in promoting liver invasion","volume":"13","author":"Rao","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.mtbio.2026.102877_bib21","article-title":"Nanomedicine in focus","volume":"1","author":"Perez","year":"2023","journal-title":"J. Basic Appl. Pharmaceut. Sci."},{"key":"10.1016\/j.mtbio.2026.102877_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202312169","article-title":"Nanomedicine tumor targeting","volume":"36","author":"Lammers","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.mtbio.2026.102877_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.23880\/nnoa-16000314","article-title":"Recent breakthroughs of nanomedicine in medical fields","volume":"9","author":"Reddy","year":"2024","journal-title":"NNOA"},{"key":"10.1016\/j.mtbio.2026.102877_bib24","unstructured":"Loading, (n.d.). https:\/\/doi.org\/10.3760\/cma.j.cn112137-20220506-00995."},{"key":"10.1016\/j.mtbio.2026.102877_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09296-6","article-title":"iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer","volume":"10","author":"Ding","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mtbio.2026.102877_bib26","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.bulcan.2023.08.009","article-title":"Cancer therapy with iRGD as a tumor-penetrating peptide","volume":"110","author":"Thirumalai","year":"2023","journal-title":"Bullet. Du Cancer"},{"key":"10.1016\/j.mtbio.2026.102877_bib27","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3390\/polym12091906","article-title":"iRGD peptide as a tumor-penetrating enhancer for tumor-targeted drug delivery","volume":"12","author":"Kang","year":"2020","journal-title":"Polymers"},{"key":"10.1016\/j.mtbio.2026.102877_bib28","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.actbio.2024.02.007","article-title":"Nanoparticle-mediated blockade of CXCL12\/CXCR4 signaling enhances glioblastoma immunotherapy: monitoring early responses with MRI radiomics","volume":"177","author":"Wei","year":"2024","journal-title":"Acta Biomater."},{"key":"10.1016\/j.mtbio.2026.102877_bib29","author":"wu"},{"key":"10.1016\/j.mtbio.2026.102877_bib30","article-title":"FN1 from cancer-associated fibroblasts orchestrates pancreatic cancer metastasis via integrin-PI3K\/AKT signaling","volume":"15","author":"Zhu","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mtbio.2026.102877_bib31","doi-asserted-by":"crossref","first-page":"328","DOI":"10.12677\/hjbm.2025.152039","article-title":"Research progress on PI3K\/AKT\/mTOR signaling pathway and multidrug resistance in breast cancer","volume":"15","author":"Chen","year":"2025","journal-title":"HJBM"},{"key":"10.1016\/j.mtbio.2026.102877_bib32","doi-asserted-by":"crossref","first-page":"575","DOI":"10.11569\/wcjd.v16.i6.575","article-title":"PI3K\/Akt\/p27kip1 pathway mediates chemoresistance to etoposide and doxorubicin in gastric carcinoma cell line BGC-823 and its mechanism","volume":"16","author":"Zhang","year":"2008","journal-title":"WCJD"},{"key":"10.1016\/j.mtbio.2026.102877_bib33","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.3390\/cancers17183076","article-title":"PARP3 promotes AML progression via activation of PI3K\/AKT\/mTOR signaling","volume":"17","author":"Cao","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.mtbio.2026.102877_bib34","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-025-02267-0","article-title":"Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies","volume":"24","author":"Pouyan","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mtbio.2026.102877_bib35","series-title":"Gallbladder Cancer: Epidemiology and Outcome, CLEP","first-page":"99","author":"Shaffer","year":"2014"},{"key":"10.1016\/j.mtbio.2026.102877_bib36","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-019-1016-0","article-title":"Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy","volume":"18","author":"Cai","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mtbio.2026.102877_bib37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.semcdb.2021.04.001","article-title":"The emerging role of miRNA in the perturbation of tumor immune microenvironment in chemoresistance: therapeutic implications","volume":"124","author":"Mondal","year":"2022","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.mtbio.2026.102877_bib38","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-019-0701-2","article-title":"Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1\/CEBPB\/NF-\u03baB signaling","volume":"7","author":"Wang","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.mtbio.2026.102877_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2012.00245","article-title":"The role of the PI3K signaling pathway in CD4+ T cell differentiation and function","volume":"3","author":"Han","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2026.102877_bib40","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1007\/s11010-022-04461-w","article-title":"Phosphoinositide 3-kinase\/Akt and its related signaling pathways in the regulation of tumor-associated macrophages polarization","volume":"477","author":"Yang","year":"2022","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.mtbio.2026.102877_bib41","doi-asserted-by":"crossref","first-page":"7091","DOI":"10.1002\/anie.201601273","article-title":"Ultra\u2010pH\u2010Responsive and tumor\u2010penetrating nanoplatform for targeted siRNA delivery with robust anti\u2010cancer efficacy","volume":"55","author":"Xu","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.mtbio.2026.102877_bib42","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.canlet.2021.09.004","article-title":"Worldwide distribution, associated factors, and trends of gallbladder cancer: a global country-level analysis","volume":"521","author":"Huang","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.mtbio.2026.102877_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-020-0134-x","article-title":"Molecular principles of metastasis: a hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.mtbio.2026.102877_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41421-022-00445-8","article-title":"Single-cell dissection of remodeled inflammatory ecosystem in primary and metastatic gallbladder carcinoma","volume":"8","author":"Wang","year":"2022","journal-title":"Cell Discov."},{"key":"10.1016\/j.mtbio.2026.102877_bib45","article-title":"Impact of HMGB1 on cancer development and therapeutic insights focused on CNS malignancy","volume":"1879","author":"Patra","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.mtbio.2026.102877_bib46","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-023-02262-9","article-title":"SLFN11 promotes clear cell renal cell carcinoma progression via the PI3K\/AKT signaling pathway","volume":"41","author":"Wang","year":"2024","journal-title":"Med. Oncol."},{"key":"10.1016\/j.mtbio.2026.102877_bib47","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/s41374-020-0451-2","article-title":"Fibronectin 1 activates WNT\/\u03b2-catenin signaling to induce osteogenic differentiation via integrin \u03b21 interaction","volume":"100","author":"Yang","year":"2020","journal-title":"Lab. Invest."},{"key":"10.1016\/j.mtbio.2026.102877_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2025.103094","article-title":"ATF5 inhibits autophagy and the Wnt\/\u03b2-catenin pathway by upregulating mTOR to suppress the stemness of liver cancer stem cells","volume":"97","author":"Jiang","year":"2025","journal-title":"Tissue Cell"},{"key":"10.1016\/j.mtbio.2026.102877_bib49","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K pathway in human disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.mtbio.2026.102877_bib50","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/030089160409000102","article-title":"Phosphoinositide 3-kinase signalling pathways in tumor progression, invasion and angiogenesis","volume":"90","author":"Brader","year":"2004","journal-title":"Tumori"},{"key":"10.1016\/j.mtbio.2026.102877_bib51","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1042\/BJ20112092","article-title":"PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances","volume":"442","author":"So","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.mtbio.2026.102877_bib52","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature20554","article-title":"Overcoming resistance to checkpoint blockade therapy by targeting PI3K\u03b3 in myeloid cells","volume":"539","author":"De Henau","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.mtbio.2026.102877_bib53","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","article-title":"MAP kinase signalling pathways in cancer","volume":"26","author":"Dhillon","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.mtbio.2026.102877_bib54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","article-title":"TGF\u03b2 in cancer","volume":"134","author":"Massagu\u00e9","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.mtbio.2026.102877_bib55","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-022-02287-3","article-title":"Targeted therapies for cancer","volume":"20","author":"Zhou","year":"2022","journal-title":"BMC Med."},{"key":"10.1016\/j.mtbio.2026.102877_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127219","article-title":"Development of curcumin-loaded galactosylated chitosan-coated nanoparticles for targeted delivery of hepatocellular carcinoma","volume":"253","author":"Huang","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.mtbio.2026.102877_bib57","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2147\/IJN.S121881","article-title":"Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile","volume":"12","author":"Rafiei","year":"2017","journal-title":"IJN"},{"key":"10.1016\/j.mtbio.2026.102877_bib58","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s12274-020-2684-1","article-title":"PLGA nanodepots co-encapsulating prostratin and anti-CD25 enhance primary natural killer cell antiviral and antitumor function","volume":"13","author":"Sweeney","year":"2020","journal-title":"Nano Res."},{"key":"10.1016\/j.mtbio.2026.102877_bib59","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-022-01282-8","article-title":"Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets","volume":"15","author":"Tie","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.mtbio.2026.102877_bib60","article-title":"Adaptive mechanisms of tumor therapy resistance driven by tumor microenvironment","volume":"9","author":"Wu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.mtbio.2026.102877_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-020-00449-4","article-title":"Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy","volume":"6","author":"Tang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.mtbio.2026.102877_bib62","first-page":"73","article-title":"Regulatory T cells (Treg) and their roles in immune system with respect to immunopathological disorders","volume":"53","author":"Kond\u011blkov\u00e1","year":"2010","journal-title":"Acta Med."},{"key":"10.1016\/j.mtbio.2026.102877_bib63","doi-asserted-by":"crossref","first-page":"7493","DOI":"10.3390\/ijms24087493","article-title":"Tumor-associated macrophage subsets: shaping polarization and targeting","volume":"24","author":"Zhang","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.mtbio.2026.102877_bib64","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.3390\/cancers13164040","article-title":"PI3K\/Akt pathway: the indestructible role of a vintage target as a support to the Most recent immunotherapeutic approaches","volume":"13","author":"Caforio","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.mtbio.2026.102877_bib65","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.semcancer.2017.04.015","article-title":"PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux","volume":"48","author":"O\u2019Donnell","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.mtbio.2026.102877_bib66","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1021\/acsami.8b18697","article-title":"ROS-sensitive cross-linked polyethylenimine for red-light-activated siRNA therapy","volume":"11","author":"Wang","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.mtbio.2026.102877_bib67","doi-asserted-by":"crossref","DOI":"10.1186\/s43066-023-00253-z","article-title":"Histopathological categorization of desmoplastic reaction in gallbladder carcinoma: its relation to cancer invasiveness and prognostic utility","volume":"13","author":"Baruah","year":"2023","journal-title":"Egypt Liver J."},{"key":"10.1016\/j.mtbio.2026.102877_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2013.00193","article-title":"Strategies to increase drug penetration in solid tumors","volume":"3","author":"Choi","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.mtbio.2026.102877_bib69","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-021-01908-8","article-title":"Fibronectin as a multiregulatory molecule crucial in tumor matrisome: from structural and functional features to clinical practice in oncology","volume":"40","author":"Spada","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.mtbio.2026.102877_bib70","first-page":"167","article-title":"Preparation and in Vitro\/in vivo evaluation of resveratrol loaded PLGA nanoparticles","volume":"38","author":"Shen","year":"2021","journal-title":"Chin. J. Moder. Appl. Pharm."},{"key":"10.1016\/j.mtbio.2026.102877_bib71","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.548","article-title":"Targeting integrin \u03b1v\u03b23 with indomethacin inhibits patient\u2010derived xenograft tumour growth and recurrence in oesophageal squamous cell carcinoma","volume":"11","author":"Liu","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.mtbio.2026.102877_bib72","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2011.09.004","article-title":"Vascular endothelial growth factor-D promotes growth, lymphangiogenesis and lymphatic metastasis in gallbladder cancer","volume":"314","author":"Lin","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.mtbio.2026.102877_bib73","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-021-02186-0","article-title":"Epigenetic activation of the elongator complex sensitizes gallbladder cancer to gemcitabine therapy","volume":"40","author":"Xu","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.mtbio.2026.102877_bib74","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1002\/cam4.1682","article-title":"MiR\u2010335\u20105p restores cisplatin sensitivity in ovarian cancer cells through targeting BCL2L2","volume":"7","author":"Liu","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.mtbio.2026.102877_bib75","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s12276-020-00510-w","article-title":"METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner","volume":"53","author":"Pan","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.mtbio.2026.102877_bib76","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/10717544.2017.1422300","article-title":"Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer","volume":"25","author":"Wu","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.mtbio.2026.102877_bib77","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001946","article-title":"Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3","volume":"9","author":"Zhou","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.mtbio.2026.102877_bib78","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jhep.2020.11.037","article-title":"CD40-mediated immune cell activation enhances response to anti-PD-1 in murine intrahepatic cholangiocarcinoma","volume":"74","author":"Diggs","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mtbio.2026.102877_bib79","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3390\/pathogens12091084","article-title":"Main cardiac histopathologic alterations in the acute phase of Trypanosoma cruzi infection in a murine model","volume":"12","author":"de Alba Alvarado","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.mtbio.2026.102877_bib80","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1369\/00221554251318435","article-title":"Development of an ALK-positive non-small-cell lung cancer in vitro tumor 3D culture model for therapeutic screening","volume":"73","author":"Berry","year":"2025","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.mtbio.2026.102877_bib81","series-title":"Picogram-Level Nanoplastic Analysis with Nanoelectromechanical System Fourier Transform Infrared Spectroscopy: NEMS-FTIR","author":"Timarac-Popovi\u0107","year":"2025"},{"key":"10.1016\/j.mtbio.2026.102877_bib82","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1134\/S1990750824600304","article-title":"CUL5 is involved in proteasome-degradation of BiP in breast cancer cells","volume":"18","author":"Ryu","year":"2024","journal-title":"Biochem. Moscow Suppl. Ser. B."}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426001201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426001201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:37:07Z","timestamp":1778906227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426001201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":82,"alternative-id":["S2590006426001201"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.102877","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting FN1 to overcome gemcitabine resistance in gallbladder cancer: Mechanistic insights and an iRGD-modified PEG-PLGA nanoparticle delivery strategy","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.102877","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102877"}}